| 1 | who we are industry | | | | | | | 1 | 0.45% |
| 2 | services and reshaping the | | | | | | | 1 | 0.45% |
| 3 | shared a bold vision | | | | | | | 1 | 0.45% |
| 4 | a bold vision for | | | | | | | 1 | 0.45% |
| 5 | bold vision for building | | | | | | | 1 | 0.45% |
| 6 | vision for building a | | | | | | | 1 | 0.45% |
| 7 | for building a global | | | | | | | 1 | 0.45% |
| 8 | building a global leader | | | | | | | 1 | 0.45% |
| 9 | a global leader in | | | | | | | 1 | 0.45% |
| 10 | commercialization services and reshaping | | | | | | | 1 | 0.45% |
| 11 | and reshaping the bio | | | | | | | 1 | 0.45% |
| 12 | beginning we’ve shared a | | | | | | | 1 | 0.45% |
| 13 | reshaping the bio pharmaceutical | | | | | | | 1 | 0.45% |
| 14 | industry jll has been | | | | | | | 1 | 0.45% |
| 15 | jll has been an | | | | | | | 1 | 0.45% |
| 16 | has been an unwavering | | | | | | | 1 | 0.45% |
| 17 | been an unwavering supporter | | | | | | | 1 | 0.45% |
| 18 | an unwavering supporter and | | | | | | | 1 | 0.45% |
| 19 | unwavering supporter and partner | | | | | | | 1 | 0.45% |
| 20 | supporter and partner to | | | | | | | 1 | 0.45% |
| 21 | and partner to us | | | | | | | 1 | 0.45% |
| 22 | we’ve shared a bold | | | | | | | 1 | 0.45% |
| 23 | business development from the | | | | | | | 1 | 0.45% |
| 24 | deep domain expertise keen | | | | | | | 1 | 0.45% |
| 25 | and platform expansion — | | | | | | | 1 | 0.45% |
| 26 | extends partnership far beyond | | | | | | | 1 | 0.45% |
| 27 | partnership far beyond capital | | | | | | | 1 | 0.45% |
| 28 | far beyond capital investment | | | | | | | 1 | 0.45% |
| 29 | acumen operational strategy capital | | | | | | | 1 | 0.45% |
| 30 | operational strategy capital markets | | | | | | | 1 | 0.45% |
| 31 | strategy capital markets and | | | | | | | 1 | 0.45% |
| 32 | capital markets and platform | | | | | | | 1 | 0.45% |
| 33 | markets and platform expansion | | | | | | | 1 | 0.45% |
| 34 | we are industry expertise | | | | | | | 1 | 0.45% |
| 35 | markets business development from | | | | | | | 1 | 0.45% |
| 36 | all inhouse with jll | | | | | | | 1 | 0.45% |
| 37 | inhouse with jll meet | | | | | | | 1 | 0.45% |
| 38 | with jll meet our | | | | | | | 1 | 0.45% |
| 39 | jll meet our team | | | | | | | 1 | 0.45% |
| 40 | meet our team investment | | | | | | | 1 | 0.45% |